Tuberculosis comorbidity with communicable and noncommunicable diseases

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 11, 2015, Pages

  Bates, Matthew ^a,b   Marais, Ben J ^c   Zumla, Alimuddin ^d  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c University of Sydney   (Australia)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COMMUNICABLE DISEASE; DIABETES MELLITUS; HEALTH SERVICE; HELMINTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; LUNG TUBERCULOSIS; MALARIA; MALNUTRITION; NON COMMUNICABLE DISEASE; NONHUMAN; COMMUNICABLE DISEASES; COMORBIDITY; HELMINTHIASIS; HIV INFECTIONS; INFLUENZA, HUMAN; RISK FACTOR; TUBERCULOSIS, PULMONARY;

COMMUNICABLE DISEASES; COMORBIDITY; DIABETES MELLITUS; HELMINTHIASIS; HIV INFECTIONS; HUMANS; INFLUENZA, HUMAN; MALARIA; MALNUTRITION; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84942801381     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a017889     Document Type: Article

References (92)

1. Adeyi OSO, Robles S. 2007. Public policy and the challenge of chronic noncommunicable diseases. World Bank, Washington, DC.
2. Adhikari M, Jeena P, Bobat R, Archary M, Naidoo K, Coutsoudis A, Singh R, Nair N. 2011. HIV-associated tuberculosis in the newborn and young infant. Int J Pediatr 2011: 354208.
3. Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, Nelwan RH, Parwati I, van der Meer JW, van Crevel R. 2007. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 45: 428-435.
4. Archer B, Cohen C, Naidoo D, Thomas J, Makunga C, Blumberg L, Venter M, Timothy G, Puren A,McAnerney J, et al. 2009. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: Epidemiology and factors associated with fatal cases. Euro Surveill 14: 19369.
5. Arentz M, Pavlinac P, Kimerling ME, Horne DJ, Falzon D, Schunemann HJ, Royce S, Dheda K, Walson JL, group ARTs. 2012. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: A systematic review. PloS ONE 7: e47370.
6. Babu S, Bhat SQ, Kumar NP, Anuradha R, Kumaran P, Gopi PG, Kolappan C, Kumaraswami V, Nutman TB. 2009. Attenuation of toll-like receptor expression and function in latent tuberculosis by coexistent filarial infection with restoration following antifilarial chemotherapy. PLoS Negl Trop Dis 3: e489.
7. Banfield S, Pascoe E, Thambiran A, Siafarikas A, Burgner D. 2012. Factors associated with the performance of a blood-based interferon-g release assay in diagnosing tuberculosis. PloS ONE 7: e38556.
8. Bates M, O'Grady J,Mwaba P, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, et al. 2012. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PloS ONE 7: e40774.
9. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, Mbanya JC, McKee M, Moodie R, Nishtar S, et al. 2011. UN high-level meeting on non-communicable diseases: Addressing four questions. Lancet 378: 449-455.
10. Bekker A, Du Preez K, Schaaf HS, Cotton MF, Hesseling AC. 2012. High tuberculosis exposure among neonates in a high tuberculosis and human immunodeficiency virus burden setting. Int J Tuberc Lung Dis 16: 1040-1046.
11. Bhargava A, Chatterjee M, Jain Y, Chatterjee B, Kataria A, Bhargava M, Kataria R, D'Souza R, Jain R, Benedetti A, et al. 2013. Nutritional status of adult patients with pulmo- nary tuberculosis in rural central India and its association with mortality. PloS ONE 8: e77979.
12. Bhaskaram P. 2002. Micronutrient malnutrition, infection, and immunity: An overview. Nutr Rev 60: S40-S45.
13. Black GF,Weir RE, Floyd S, Bliss L,Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, et al. 2002. BCG-induced increase in interferon-γ response to mycobacterial antigens and efficacy of BCG vaccination inMalawi and the UK: Two randomised controlled studies. Lancet 359: 1393-1401.
14. Chintu C, Bhat G, Luo C, Raviglione M, Diwan V, Dupont HL, Zumla A. 1993. Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosis. Pediatr Infect Dis J 12: 499-504.
15. Co DO, Hogan LH, Karman J, Heninger E, Vang S,Wells K, Kawaoka Y, Sandor M. 2006. Interactions between T cells responding to concurrent mycobacterial and influenza infections. J Immunol 177: 8456-8465.
16. Creswell J, Raviglione M, Ottmani S, Migliori GB, Uplekar M, Blanc L, Sotgiu G, Lönnroth K. 2011. Tuberculosis and non-communicable diseases: Neglected links and missed opportunities. Eur Respir J 37: 1269-1282.
17. de Paus RA, van Crevel R, van Beek R, Sahiratmadja E, Alisjahbana B, Marzuki S, Rimmelzwaan GF, van Dissel JT, Ottenhoff TH, van de Vosse E. 2013. The influence of influenza virus infections on the development of tuberculosis. Tuberculosis 93: 338-342.
18. Dodor E. 2008. Evaluation of nutritional status of new tuberculosis patients at the Effia-Nkwanta Regional hospital. Ghana Med J 42: 22-28.
19. Dooley KE, Chaisson RE. 2009. Tuberculosis and diabetes mellitus: Convergence of two epidemics. Lancet Infect Dis 9: 737-746.
20. Dooley KE, Tang T, Golub JE, Dorman SE, CroninW. 2009. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80: 634-639.
21. du Plessis N, Kleynhans L, Thiart L, van Helden PD, Brombacher F, Horsnell WG, Walzl G. 2013. Acute helminth infection enhances early macrophage mediated control of mycobacterial infection. Mucosal Immunol 6: 931-941.
22. Enwere GC, Ota MO, Obaro SK. 1999. The host response in malaria and depression of defence against tuberculosis. Ann Trop Med Parasitol 93: 669-678.
23. Florido M, Grima MA, Gillis CM, Xia Y, Turner SJ, Triccas JA, Stambas J, Britton WJ. 2013. Influenza Avirus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection. J Immunol 191: 302-311.
24. Frantz FG, Rosada RS, Peres-Buzalaf C, Perusso FR, RodriguesV, Ramos SG,Kunkel SL, Silva CL, Faccioli LH. 2010. Helminth coinfection does not affect therapeutic effect of a DNAvaccine in mice harboring tuberculosis. PLoS Negl Trop Dis 4: e700.
25. Geneau R, Hallen G. 2012. Toward a systemic research agenda for addressing the joint epidemics of HIV/AIDS and noncommunicable diseases. AIDS 31: S7-S10.
26. Gengiah TN, Gray AL, Naidoo K, Karim QA. 2011. Initiating antiretrovirals during tuberculosis treatment: A drug safety review. Expert Opin Drug Saf 10: 559-574.
27. Greenberg BL, Weisfuse IB, Makki H, Adler J, el-Sadr W, Clarke L, Gainey S, Alford T, McFarlane K, Thomas PA. 1994. HIV-1 seroprevalence in chest clinic and hospital tuberculosis patients inNew York City, 1989-1991. AIDS 8: 957-962.
28. Guler M, Unsal E, Dursun B, Aydln O, Capan N. 2007. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 61: 231-235.
29. Hawkes M, Li X, Crockett M, Diassiti A, Liles WC, Liu J, Kain KC. 2010. Malaria exacerbates experimental mycobacterial infection in vitro and in vivo. Microbes Infect 12: 864-874.
30. Hubner MP, Killoran KE, Rajnik M, Wilson S, Yim KC, Torrero MN, Morris CP, Nikonenko B, Blanco JC, Hemming VG, et al. 2012. Chronic helminth infection does not exacerbate Mycobacterium tuberculosis infection. PLoS Negl Trop Dis 6: e1970.
31. Ismail I, Bulgiba A. 2013. Predictors of death during tuberculosis treatment in TB/HIV co-infected patients in Malaysia. PloS ONE 8: e73250.
32. Jaganath D, Mupere E. 2012. Childhood tuberculosis and malnutrition. J Infect Dis 206: 1809-1815.
33. Jeon CY, Murray MB. 2008. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Med 5: e152.
34. Kennedy N, Ramsay A, Uiso L, Gutmann J, Ngowi FI, Gillespie SH. 1996. Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania. Trans R Soc Trop Med Hyg 90: 162-166.
35. Kim DK, Kim HJ, Kwon SY, Yoon HI, Lee CT, Kim YW, Chung HS, Han SK, Shim YS, Lee JH. 2008. Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis. Eur Respir J 32: 1031-1036.
36. Kivihya-Ndugga LE, Ochola JJ, Otieno G, Muthami LN, Gathua S. 1994a. Clinical and immunological markers in Kenyan pulmonary tuberculosis patients with and without HIV-1. East Afr Med J 71: 373-375.
37. Kivihya-Ndugga LE, Otieno G, Muthami LN, Gachihi G, Gathua S. 1994b.Markers in HIVassociated tuberculosis in Kenya. Afr J Health Sci 1: 122-125.
38. Lalremruata A, Ball M, Bianucci R, Welte B, Nerlich AG, Kun JF, Pusch CM. 2013. Molecular identification of falciparum malaria and human tuberculosis co-infections in mummies from the Fayum depression (Lower Egypt). PloS ONE 8: e60307.
39. Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC. 2008. Diabetic control and risk of tuberculosis: A cohort study. Am J Epidemiol 167: 1486-1494.
40. Li L, Lin Y, Mi F, Tan S, Liang B, Guo C, Shi L, Liu L, Gong F, Li Y, et al. 2012. Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health 17: 1294-1301.
41. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair- Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al. 2012. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: Asystematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224-2260.
42. Lin Y, Li L, Mi F, Du J, Dong Y, Li Z, Qi W, Zhao X, Cui Y, Hou F, et al. 2012. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health 17: 1302-1308.
43. Lönnroth K, Castro K, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione M. 2010. Tuberculosis control and elimination 2010-50: Cure, care, and social development. Lancet 375: 1814-1829.
44. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. 2012. Global and regional mortality from235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128.
45. Marais BJ, Lonnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, et al. 2013. Tuberculosis comorbidity with communicable and non-communicable diseases: Integrating health services and control efforts. Lancet Infect Dis 13: 436-448.
46. Martin DJ, Sim JG, Sole GJ, Rymer L, Shalekoff S, van Niekerk AB, Becker P,Weilbach CN, Iwanik J, Keddy K, et al. 1995. CD4þ lymphocyte count in African patients coinfected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol 8: 386-391.
47. Mboussa J, Monabeka H, Kombo M, Yokolo D, Yoka-Mbio A, Yala F. 2003. Rev Pneumol Clin 59: 39-44. [Course of pulmonary tuberculosis in diabetics.]
48. Moore DP, Klugman KP, Madhi SA. 2010. Role of Streptococcus pneumoniae in hospitalization for acute community- acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: A pneumococcal conjugate vaccine probe study. Pediatr Infect Dis J 29: 1004-1099.
49. Morsy AM, Zaher HH, Hassan MH, Shouman A. 2003. Predictors of treatment failure among tuberculosis patients under DOTS strategy in Egypt. East Mediterr Health J 9: 689-701.
50. Mueller AK, Behrends J, Hagens K, Mahlo J, Schaible UE, Schneider BE. 2012.Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PloS ONE 7: e48110.
51. Mupere E, Malone L, Zalwango S, Chiunda A, Okwera A, Parraga I, Stein CM, Tisch DJ,Mugerwa R, Boom WH, et al. 2012. Lean tissue mass wasting is associated with increased risk of mortality among women with pulmonary tuberculosis in urban Uganda. Ann Epidemiol 22: 466- 473.
52. Murphy ME, Singh KP, Laurenzi M, Brown M, Gillespie SH. 2012. Managing malaria in tuberculosis patients on fluoroquinolone- containing regimens: Assessing the risk of QTprolongation. Int J Tuberc Lung Dis 16: 144-149, i-iii.
53. Nijland HM, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, Nelwan RH, van der Ven AJ, Danusantoso H, Aarnoutse RE, van Crevel R. 2006. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis 43: 848-854.
54. Noh JY, Lee J, ChoiWS, Song JY, Seo YB, Kim IS, Cheong HJ, Kim WJ. 2013. Concurrent tuberculosis and influenza, South Korea. Emerg Infect Dis 19: 165-167.
55. Olmos P, Donoso J, Rojas N, Landeros P, Schurmann R, Retamal G, Meza M, Martinez C. 1989. [Tuberculosis and diabetes mellitus: A longitudinal-retrospective study in a teaching hospital.] Rev Med Chil 117: 979-983.
56. Page KR, Jedlicka AE, Fakheri B, Noland GS, Kesavan AK, Scott AL, Kumar N, Manabe YC. 2005. Mycobacteriuminduced potentiation of type 1 immune responses and protection against malaria are host specific. Infect Immun 73: 8369-8380.
57. Parra M, Derrick SC, Yang A, Tian J, Kolibab K, Oakley M, Perera LP, Jacobs WR, Kumar S,Morris SL. 2011.Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice. PloS ONE 6: e28164.
58. Pelly TF, Santillan CF, Gilman RH, Cabrera LZ, Garcia E, Vidal C, Zimic MJ, Moore DA, Evans CA. 2005. Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis 9: 977-984.
59. Perry S, Chang AH, Sanchez L, Yang S, Haggerty TD, Parsonnet J. 2013. The immune response to tuberculosis infection in the setting of Helicobacter pylori and helminth infections. Epidemiol Infect 141: 1232-1243.
60. Podewils LJ, Holtz T, Riekstina V, Skripconoka V, Zarovska E, Kirvelaite G, Kreigere E, Leimane V. 2011. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients. Epidemiol Infect 139: 113-120.
61. Pozniak AL, MacLeod GA, Mahari M, Legg W, Weinberg J. 1992. The influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa. AIDS 6: 809-814.
62. Rafi W, Ribeiro-Rodrigues R, Ellner JJ, Salgame P. 2012. Coinfection-helminthes and tuberculosis. Curr Opin HIVAIDS 7: 239-244.
63. Range N, Magnussen P, Mugomela A, Malenganisho W, Changalucha J, Temu MM, Mngara J, Krarup H, Friis H, Andersen AB. 2007. HIV and parasitic co-infections in tuberculosis patients: A cross-sectional study in Mwanza, Tanzania. Ann Trop Med Parasitol 101: 343- 351.
64. Redford PS, Mayer-Barber KD,McNab FW, Stavropoulos E, Wack A, Sher A, O'Garra A. 2014. Influenza Avirus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J Infect Dis 15: 270-274.
65. Remais JV, Zeng G, Li G, Tian L, Engelgau MM. 2013. Convergence of non-communicable and infectious diseases in low- and middle-income countries. Int J Epidemiol 42: 221-227.
66. Restrepo BI, Fisher-Hoch SP, Smith B, Jeon S, Rahbar MH, McCormick JB, Nuevo Santander Tuberculosis T. 2008. Mycobacterial clearance from sputum is delayed during the first phase of treatment in patientswith diabetes.AmJ Trop Med Hyg 79: 541-544.
67. Roth S, Whitehead S, Thamthitiwat S, Chittaganpitch M, Maloney SA, Baggett HC, Olsen SJ. 2013. Concurrent influenza virus infection and tuberculosis in patients hospitalized with respiratory illness in Thailand. Influenza Other Respir Viruses 7: 244-248.
68. Salive ME, Vlahov D, Brewer TF. 1990. Coinfection with tuberculosis and HIV-1 in male prison inmates. Public Health Rep 105: 307-310.
69. Sbrana E, Grise J, Stout C, Aronson J. 2011. Co-morbidities associated with tuberculosis in an autopsy case series. Tuberculosis 91: S38-S42.]
70. Schaible UE, Kaufmann SH. 2007. Malnutrition and infection: Complex mechanisms and global impacts. PLoS Med 4: e115.
71. Scott CP, Kumar N, Bishai WR, Manabe YC. 2004. Short report: Modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model. Am J TropMed Hyg 70: 144-148.
72. Singh NB, Singh EK, Singh HL, Singh YI. 1993. Tuberculosis/ HIV co-infection in India's north-eastern states. J Infect 26: 344-345.
73. Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM. 2006. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 10: 74-79.
74. Sinnis P, Ernst JD. 2008. CO-opting the host HO-1 pathway in tuberculosis and malaria.CellHost Microbe 3: 277-279.
75. Sturt AS, Dokubo EK, Sint TT. 2010. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev: CD008440.
76. Swai AB, McLarty DG, Mugusi F. 1990. Tuberculosis in diabetic patients in Tanzania. Trop Doct 20: 147-150.
77. Talaat KR, Bonawitz RE, Domenech P, Nutman TB. 2006. Preexposure to live Brugia malayi microfilariae alters the innate response of human dendritic cells to Mycobacterium tuberculosis. J Infect Dis 193: 196-204.
78. Thapa R, Mallick D, Biswas B. 2010. Perinatal malaria and tuberculosis co-infection: A case report. Int J Infect Dis 14: e254-256.
79. Uddin Siddiqui E, Ejaz K, Lone S, Raza SJ. 2010. Investment in paediatric tuberculosis prevention in Pakistan: Loss or gain? J Pak Med Assoc 60: 897-901.
80. Ullrich A, Ott JJ, Vitoria M, Martin-Moreno JM, Atun R. 2011. Long-term care of AIDS and non-communicable diseases. Lancet 377: 639-640.
81. Valadas E, Gomes A, Sutre A, Brilha S,Wete A, Hanscheid T, Antunes F. 2013. Tuberculosis with malaria or HIV co-infection in a large hospital in Luanda, Angola. J Infect Dev Ctries 7: 269-272.
82. Villamor E, Saathoff E,Mugusi F, Bosch RJ, UrassaW, Fawzi WW. 2006.Wasting and body composition of adults with pulmonary tuberculosis in relation to HIV-1 coinfection, socioeconomic status, and severity of tuberculosis. Eur J Clin Nutr 60: 163-171.
83. Viswanathan V, Kumpatla S, Aravindalochanan V, Rajan R, Chinnasamy C, Srinivasan R, Selvam JM, Kapur A. 2012. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PloS ONE 7: e41367.
84. Volberding PA, Deeks SG. 2010. Antiretroviral therapy and management of HIV infection. Lancet 376: 49-62.
85. Wammes LJ, Hamid F, Wiria AE, de Gier B, Sartono E, Maizels RM, Luty AJ, Fillie Y, Brice GT, Supali T, et al. 2010. Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur J Immunol 40: 437-442.
86. Webb EL, Mawa PA, Ndibazza J, Kizito D, Namatovu A, Kyosiimire-Lugemwa J, Nanteza B, Nampijja M, Muhangi L, Woodburn PW, et al. 2011. Effect of singledose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: A randomised, doubleblind, placebo-controlled trial. Lancet 377: 52-62.
87. WHO. 2011. Burden: Mortality, morbidity and risk factors. In Global status report on noncommunicable diseases 2010 (ed. WHO). WHO, Geneva.
88. WHO. 2013. Global tuberculosis report 2013. 306. WHO Library Cataloging-in-Publication Data, Geneva, Switzerland.
89. WHO/IUATBLD. 2011. Collaborative framework for acre and control of tuberculosis and diabetes. WHO/HTM/ 2011.15. International Union Against Tuberculosis and Lung Disease 1-53. http://whqlibdoc.who.int/publica tions/2011/9789241502252_eng.pdf.
90. Zachariah R, Spielmann MP, Harries AD, Salaniponi FM. 2002. Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans R Soc Trop Med Hyg 96: 291-294.
91. Zevallos K, Vergara KC, Vergara A, Vidal C, Garcia HH, Evans CA. 2010. Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and co-infections. Am J Trop Med Hyg 83: 319-325.
92. Zumla A, Nahid P, Cole ST. 2013. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 12: 388-404.